Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-07 5:40 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
14,113 | $341.32 | $4,817,104 | 14,383 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-04 9:24 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,227 | $341.07 | $418,488 | 3,728 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 5:03 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
103 | $335.24 | $34,530 | 4,955 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-17 7:08 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
442 | $273.41 | $120,847 | 5,058 (Direct) |
View |
| 2024-06-14 Sale |
2024-06-18 9:39 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $280 | $532,000 | 15,850 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-14 9:44 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $285 | $570,000 | 20,700 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-23 9:36 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,036 | $231.34 | $239,668 | 5,500 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $235.5 | $942,000 | 42,067 (Direct) |
View |
| 2023-12-12 Sale |
2023-12-14 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $222.82 | $846,700 | 50,567 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $273.24 | $2,732,438 | 60,667 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-05 Option Award |
2025-03-07 5:40 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,218 | $0 | 14,383 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
6,825 | $87.92 | 14,383 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
7,288 | $87.09 | 14,383 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
14,113 | $0 | 14,383 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:39 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $87.09 | 15,850 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:39 pm |
N/A 2032-02-24 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,900 | $0 | 15,850 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 9:44 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $87.92 | 20,700 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 9:44 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
2,000 | $0 | 20,700 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 5:50 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,557 | $0 | 10,093 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:45 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
550 | $243.92 | 5,117 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $87.92 | 42,067 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
4,000 | $0 | 42,067 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $87.92 | 50,567 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-14 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,800 | $0 | 50,567 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $87.92 | 60,667 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $0 | 60,667 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
5,667 | $0 | 5,667 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-24 8:17 pm |
N/A 2022-02-24 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
12,250 | $0 | 12,250 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-04 9:46 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
35,000 | $0 | 35,000 (Direct) |
View |